Fuji PharmaFuji Pharma Co.,Ltd.4554東証プライム医薬品FY ending Sep 2025, consolidated, J-GAAP

What does Fuji Pharma do with its cash?

How cash from operations was spent on investment, dividends, buybacks and more.

Operating cash flow
¥5.8B
Capex
¥3.85B
of revenue 7.5%
Free cash flow
¥1.95B
Returned to shareholders
¥1.04B
of net income: 35%
Dividend per share
¥45.5
Payout ratio (reported)
45.3%

Cash flow ratios

Cash conversion, investment and shareholder payments calculated from disclosed figures.

Net income¥3B
Operating cash flow¥5.8B
Cash conversion (operating CF ÷ operating income)
116.3%
Cash vs. profit gap
¥2.8B(純利益の 93.4%)
Shareholder payments — dividends
of net income 34.5% · of FCF 53.2%
CapEx intensity (capex ÷ revenue)
7.5%
Investing CF relative to operating CF
72.7%

Nonpositive profit and free cash flow are omitted as ratio denominators. Amounts use the period's reported currency.

Five-year trend

Operating cash flow¥5.8B
FY ending Sep 2021: ¥5.99B¥5.99BFY ending Sep 2022: -¥658M-¥658MFY ending Sep 2023: ¥1.92B¥1.92BFY ending Sep 2024: ¥4.15B¥4.15BFY ending Sep 2025: ¥5.8B¥5.8BFY21FY22FY23FY24FY25
Free cash flow¥1.95B
FY ending Sep 2021: ¥2.1B¥2.1BFY ending Sep 2022: -¥13.1B-¥13.1BFY ending Sep 2023: -¥1.98B-¥1.98BFY ending Sep 2024: -¥221M-¥221MFY ending Sep 2025: ¥1.95B¥1.95BFY21FY22FY23FY24FY25
Net income¥3B
FY ending Sep 2021: ¥2.43B¥2.43BFY ending Sep 2022: ¥2.7B¥2.7BFY ending Sep 2023: ¥3.44B¥3.44BFY ending Sep 2024: ¥6.15B¥6.15BFY ending Sep 2025: ¥3B¥3BFY21FY22FY23FY24FY25

How to read this

  • Operating cash flow is the cash the core business actually brought in, including changes in receivables and inventory.
  • Free cash flow = operating cash flow − capital expenditure: a gauge of cash available for other uses.
  • Large "borrowing" or "cash drawdown" flows mean the company spent more than it generated that year.

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第61期(2024/10/01-2025/09/30)

    ID S100XAU22025-12-18Open
  • EDINET (FSA Japan)

    有価証券報告書-第60期(2023/10/01-2024/09/30)

    ID S100UZR22024-12-23Open
  • EDINET (FSA Japan)

    有価証券報告書-第59期(2022/10/01-2023/09/30)

    ID S100SI942023-12-21Open
  • EDINET (FSA Japan)

    有価証券報告書-第58期(令和3年10月1日-令和4年9月30日)

    ID S100PTQF2022-12-21Open
  • EDINET (FSA Japan)

    有価証券報告書-第57期(令和2年10月1日-令和3年9月30日)

    ID S100N2LZ2021-12-20Open
  • EDINET (FSA Japan)

    有価証券報告書-第56期(令和1年10月1日-令和2年9月30日)

    ID S100KDTI2020-12-18Open

Extracted from XBRL: 52 / Derived from other figures: 2

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.